div class=trans-pagebuttonPage 1button div class=trans-image amp-img class=trans-thumb alt=Page 1: INICIOportalcsbpcomboinicioattachmentsarticle3780INFORMEpdf · 11 8-01-08 20 12 8-01-10 10 3 69 S-01-41 AFLIBREPT PvÞdicarTEntos Oncológicos 4 50 L-03-11 NTERFERONBETA src=https:reader033fdocumenticomreader033viewer20220502155f60b89b4fcf8763c66ade0ahtml5thumbnails1jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 2button div class=trans-image amp-img class=trans-thumb alt=Page 2: INICIOportalcsbpcomboinicioattachmentsarticle3780INFORMEpdf · 11 8-01-08 20 12 8-01-10 10 3 69 S-01-41 AFLIBREPT PvÞdicarTEntos Oncológicos 4 50 L-03-11 NTERFERONBETA src=https:reader033fdocumenticomreader033viewer20220502155f60b89b4fcf8763c66ade0ahtml5thumbnails2jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 3button div class=trans-image amp-img class=trans-thumb alt=Page 3: INICIOportalcsbpcomboinicioattachmentsarticle3780INFORMEpdf · 11 8-01-08 20 12 8-01-10 10 3 69 S-01-41 AFLIBREPT PvÞdicarTEntos Oncológicos 4 50 L-03-11 NTERFERONBETA src=https:reader033fdocumenticomreader033viewer20220502155f60b89b4fcf8763c66ade0ahtml5thumbnails3jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 4button div class=trans-image amp-img class=trans-thumb alt=Page 4: INICIOportalcsbpcomboinicioattachmentsarticle3780INFORMEpdf · 11 8-01-08 20 12 8-01-10 10 3 69 S-01-41 AFLIBREPT PvÞdicarTEntos Oncológicos 4 50 L-03-11 NTERFERONBETA src=https:reader033fdocumenticomreader033viewer20220502155f60b89b4fcf8763c66ade0ahtml5thumbnails4jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 5button div class=trans-image amp-img class=trans-thumb alt=Page 5: INICIOportalcsbpcomboinicioattachmentsarticle3780INFORMEpdf · 11 8-01-08 20 12 8-01-10 10 3 69 S-01-41 AFLIBREPT PvÞdicarTEntos Oncológicos 4 50 L-03-11 NTERFERONBETA...